Stem Cell Therapy For Multiple Myeloma

It can be a strong weapon in your fight against multiple myeloma.

Stem cell therapy for multiple myeloma. See drug therapy for multiple myeloma stem cell transplants sct can be autologous or allogeneic. It isn t a cure but it can help you feel better and maybe. With an autologous transplant the healthy stem cells are taken from the patient s own body. There are two types of stem cell transplants autologous and allogeneic.

Multiple myeloma can also be treated using drugs which can be given by mouth or directly into the bloodstream. It s still experimental but you may get a. The standard of care for fit multiple myeloma patients is to receive high dose chemotherapy hdt with autologous stem cell rescue otherwise known as autologous stem cell transplant asct after completion of induction therapy. An important component of multiple myeloma treatment is autologous stem cell transplantation asct which consists on using a patient s own healthy blood stem cells to replace diseased or damaged bone marrow.

Drug therapy for multiple myeloma stem cell transplant for multiple myeloma. An autologous stem cell transplant is more common for treating multiple myeloma. The study long term outcomes after autologous stem cell transplantation for multiple myeloma was published in the journal blood advances. Car t cell therapy for multiple myeloma researchers are finding new ways to fight multiple myeloma including a new treatment called car t cell therapy.

Before the transplant drug treatment is used to reduce the number of myeloma cells in the patient s body. 6 11 today the clinical relevance of these aforementioned trials is limited because many patients receive induction therapy containing an immunomodulatory drug imid such as lenalidomide or thalidomide with or without bortezomib a proteosome inhibitor in combination with steroids. Multiple myeloma sometimes called plasma cell myeloma or simply myeloma is a relatively uncommon form of cancer accounting for about 1 of all cancer cases according to world cancer research. For patients with standard risk disease the first period of response can last 2 3 years or.

These systemic therapies can reach cancer cells anywhere in the body. Most patients with myeloma will experience periods of sustained response or remission followed by relapses over the course of the disease. Autologous stem cell transplant can provide significant remission that is both long and deep extending survival. Stem cell transplant is commonly used to treat multiple myeloma.